Antithrombotic Treatment and Clinical Outcomes After Intracerebral Hemorrhage: A Retrospective Cohort Study from the Swedish Stroke Register
Journal of the American Heart Association · 2024
DOI: 10.1161/jaha.123.034716 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of the American Heart Association, 2024. Verfasst von Mattias Tallroth und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology and Rehabilitation, Faculty of Medicine and Health Örebro University Örebro Sweden. Hauptthemen laut MEDLINE: Registries, Cerebral Hemorrhage, Fibrinolytic Agents, Anticoagulants. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Schlaganfall
Abstract (Originalsprache)
Background A rapid shift has occurred from vitamin K antagonists toward direct oral anticoagulants, which have a lower risk of intracerebral hemorrhage (ICH). However, effects on clinical outcomes after ICH are understudied. We aimed to describe the prevalence of antithrombotic drugs and to study the prognosis among prestroke functionally independent Swedish patients with ICH. Methods and Results We identified all patients diagnosed with nontraumatic ICH in 2017 to 2021 from the Swedish Stroke Register (n=13 155) and assessed death and functional outcome at 3 months after ICH in prestroke functionally independent patients (n=10 014). Functional outcome was estimated among 3‐month survivors on the basis of self‐reported activities of daily living scores. Risks of outcomes were estimated using Poisson regression. In 13 155 patients, 14.5% used direct oral anticoagulant, 10.1% vitamin K antagonists, and 21.6% antiplatelets at ICH onset. Among 10 014 pre‐stroke activities of daily living–independent patients, oral anticoagulants and antiplatelets were associated with increased mortality risk (adjusted risk ratio, 1.27 [95% CI, 1.13–1.43]; P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology and Rehabilitation, Faculty of Medicine and Health Örebro University Örebro Sweden.
- Department of Clinical Epidemiology and Biostatistics, School of Medical Sciences, Faculty of Medicine and Health Örebro University Örebro Sweden.
- Department of Neurosurgery, Faculty of Medicine and Health Örebro University Örebro Sweden.
ORCID-Profile: Mattias Tallroth, Ruzan Udumyan, András Büki, Mia von Euler
Zitieren
APA
Tallroth, M., Udumyan, R., Büki, A., & von Euler, M. (2024). Antithrombotic Treatment and Clinical Outcomes After Intracerebral Hemorrhage: A Retrospective Cohort Study from the Swedish Stroke Register. Journal of the American Heart Association. https://doi.org/10.1161/jaha.123.034716
Vancouver
Tallroth M, Udumyan R, Büki A, von Euler M. Antithrombotic Treatment and Clinical Outcomes After Intracerebral Hemorrhage: A Retrospective Cohort Study from the Swedish Stroke Register. Journal of the American Heart Association. 2024. doi:10.1161/jaha.123.034716
BibTeX
@article{Tallroth2024,
author = {Tallroth, Mattias and Udumyan, Ruzan and Büki, András and von Euler, Mia},
title = {Antithrombotic Treatment and Clinical Outcomes After Intracerebral Hemorrhage: A Retrospective Cohort Study from the Swedish Stroke Register},
journal = {Journal of the American Heart Association},
year = {2024},
doi = {10.1161/jaha.123.034716}
}
EUVIMED